The public detente between President Donald Trump and Big Tech titans, forged in the wake of his return to power, has yet to ...
Pfizer CEO Albert Bourla supports Trump administration at PhRMA Forum, while CDC postpones vaccine advisory meeting. Atomwise names Steve Worland as CEO, and Biogen licenses Dravet drug.
Trump Ignites Controversy at Black History Month Event** Amidst the backdrop of a politically charged climate, President Donald Trump recently found himself i ...
The FDA determined that Novo Nordisk’s obesity and diabetes drugs are no longer in short supply. Elsewhere, Concentra made a ...
Pfizer may appeal to income investors, but growth prospects remain uncertain. Read why PFE stock might struggle to gain ...
The future of the CDC’s vaccine advisory committee seems uncertain: A scheduled February meeting for the ACIP, which advises ...
A study by KFF found that one in four Republican parents now say they've skipped or delayed some childhood vaccines as of ...
President Donald Trump's introduction of a Pfizer executive at the White House Wednesday was met with a roar of boos from the crowd.
US President Donald Trump was joined by golfer Tiger Woods for an event marking Black History Month Thursday -- even as his ...
The meeting, which will include Pfizer CEO Albert Bourla as the newly named board of directors’ chair, will reportedly cover ...
As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...
Pfizer (NYSE: PFE) has hit a bit of a rough patch, after doing well with its COVID vaccine and Paxlovid treatment. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results